The 2027 Financial Health Checklist for Cannabis Operators - Grab Your Seat for the Free Webinar Now!
The 2027 Financial Health Checklist for Cannabis Operators - Grab Your Seat for the Free Webinar Now!
Tag: CBT > DEA Cannabis Policy and Legalization | Cannabis Business Times
Subscribe
Sign In
Tag: CBT > DEA Cannabis Policy and Legalization: Page 4
Legislation and Regulation
DEA, Attorney General Miss Deadline to Respond to 12 US Senators on Cannabis Rescheduling
The Drug Enforcement Administration continues to keep its process behind closed doors despite a congressional letter demanding transparency.
February 14, 2024
Cannabis Rescheduling
Congressman Presses DEA For Answers on Ongoing Cannabis Scheduling Review
U.S. Rep. Earl Blumenauer wrote to DEA Administrator Anne Milgram Feb. 8 for further details on the review process, including when the agency might publish its draft rule on the scheduling of cannabis.
February 8, 2024
Cannabis Rescheduling
US Congressman Attempts to Sway DEA From Rescheduling Cannabis
Rep. Andy Harris claims the FDA’s eight-factor analysis on cannabis was “flawed,” leading to a “misguided” recommendation to reschedule.
February 2, 2024
Legislation and Regulation
12 US Senators Say Cannabis Should Be Descheduled, Demand Transparency From DEA
The dozen Democrats requested responses to six questions regarding the DEA’s rescheduling process.
January 30, 2024
Cannabis Retail Price
Rescheduling, Legalization Prospects Top CBT's Most-Read Articles in January
Here are Cannabis Business Times’ top 10 stories this month.
January 25, 2024
Cannabis Rescheduling
US Congressman Urges DEA to Expedite Rescheduling Cannabis
Rep. Steve Cohen of Tennessee wrote a letter to Administrator Anne Milgram pushing to initiate the rulemaking process “quickly.”
January 5, 2024
Cannabis Rescheduling
Industry Attorney Weighs in on Possible Cannabis Rescheduling Timeline: ‘It Normally Takes Years and Years for This to Get Done’
Despite the U.S. Drug Enforcement Administration’s recent response to a letter from Rep. Earl Blumenauer urging the agency to deschedule cannabis, Porter Wright Morris & Arthur’s Shane Pennington says it could be after the 2024 election before federal officials come to a decision on cannabis’s Schedule I status.
January 4, 2024
Florida
5 Cannabis Policy Reform Efforts to Watch in 2024
From the SAFER Banking Act to state-level reform, Akerman’s Jonathan Robbins outlines the legislation and potential policy changes on the horizon for the industry.
December 27, 2023
Cannabis Rescheduling
Former US Attorneys Urge Federal Officials to Reject Cannabis Rescheduling Recommendation
Eric Berlin, partner at Dentons, shares insight into some of the arguments the 29 former attorneys make against removing cannabis from Schedule I of the Controlled Substances Act.
December 21, 2023
Georgia
‘We Won’t Stop Working for Patient Access’: Georgia Regulators Weigh Options After Receiving DEA Warning About Pharmacies Dispensing Medical Cannabis
Georgia Access to Medical Cannabis Commission members said during a Dec. 13 meeting that the DEA’s recent warning highlights conflicting federal and state cannabis policy and they plan to continue fighting for patient access.
December 14, 2023
Ohio
The Top 10: CBT's Most-Read Articles in November
Here's a recap and list of the stories readers engaged most with this month.
November 29, 2023
Cannabis Rescheduling
US Sen. Kirsten Gillibrand Calls on DEA to Reclassify Cannabis as Schedule III
The New York Democrat says cannabis “is simply not comparable to other Schedule I substances like heroin, LSD and MDMA.”
November 21, 2023
Previous Page
Page 4 of 8
Next Page